← Leaderboards
Jay T. Evans
University Of Montana
$1,972,986
Attributed
$2,983,197
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,983,197 · 3
By mechanism
R33$1,067,980 · 1
R01$962,774 · 1
R61$952,443 · 1
Top collaborators
- Shabaana A. Khader3 shared
Most similar at University Of Montana
Same institution · by research overlap
- Patrick R Secor$6,304,071
- Sophia Raff Newcomer$3,854,517
- Curtis William Noonan$13,652,734
Others in their field
Other Rising Stars on “Vaccine Formulation”
- Kevin Saunders · Duke University$18,205,751
- Elizabeth Norton · Tulane University Of Louisiana$11,287,780
- Warwick Britton · University Of Sydney$10,964,476
- Jeff T Hutchins · Inhalon Biopharma, Inc.$9,192,272
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Li Liang · University Of California-Irvine$7,511,446
Research focus
Vaccine FormulationImmune ResponseRouteAdjuvantVaccine CandidateImmunityMouse ModelResistant StrainVaccine EfficacyVaccinesAntigensEfficacy EvaluationPreventPathogenGeneticAgonistGrantBacille Calmette-Guerin VaccinationFundingFutureHelper-Inducer T-LymphocyteCellsEfficacy TestingAerosols
Grant awards (4)
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine$1,067,980
R33 · FY2025 · AI
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine$472,273
R61 · FY2024 · AI
Development of a novel adjuvanted Th1- and Th17-inducing subunit TB Vaccine$480,170
R61 · FY2023 · AI
Immunization against filamentous bacteriophages to prevent bacterial infection$962,774
R01 · FY2022 · AI · contact PI